CannPal (ASX:CP1) Introduction to CannPal and Investment Outlook
CannPal Animal Therapeutics (ASX:CP1) Founder and Managing Director Layton Mills discusses animal health company’s investment outlook.
Mr Mills details how the Company is well positioned to capitalise on a significant market opportunity in the animal health sector.
Learn more at http://cannpal.com
Mr Mills details how the Company is well positioned to capitalise on a significant market opportunity in the animal health sector.
Learn more at http://cannpal.com
People In This Video
No users are tagged in this video